209 related articles for article (PubMed ID: 29410540)
1. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program.
Christensen RD; Baer VL; MacQueen BC; O'Brien EA; Ilstrup SJ
J Perinatol; 2018 May; 38(5):517-525. PubMed ID: 29410540
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study.
Xu C; Bao Y; He Y; Wu M; Zhu J
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760
[TBL] [Abstract][Full Text] [Related]
3. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system.
Eggert LD; Wiedmeier SE; Wilson J; Christensen RD
Pediatrics; 2006 May; 117(5):e855-62. PubMed ID: 16651290
[TBL] [Abstract][Full Text] [Related]
4. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
5. Absence of severe neonatal ABO hemolytic disease at Intermountain Healthcare. Why?
Baer VL; Hulse W; Bahr TM; Ilstrup SJ; Christensen RD
J Perinatol; 2020 Feb; 40(2):352-353. PubMed ID: 31796840
[No Abstract] [Full Text] [Related]
6. Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: a prospective cohort study.
Kalakheti BK; Singh R; Bhatta NK; Karki A; Baral N
Kathmandu Univ Med J (KUMJ); 2009; 7(25):11-5. PubMed ID: 19483446
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia.
Gamaleldin R; Iskander I; Seoud I; Aboraya H; Aravkin A; Sampson PD; Wennberg RP
Pediatrics; 2011 Oct; 128(4):e925-31. PubMed ID: 21911352
[TBL] [Abstract][Full Text] [Related]
8. Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.
Kaplan M; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
J Pediatr; 2010 Nov; 157(5):772-7. PubMed ID: 20598320
[TBL] [Abstract][Full Text] [Related]
9. Causes of hemolysis in neonates with extreme hyperbilirubinemia.
Christensen RD; Nussenzveig RH; Yaish HM; Henry E; Eggert LD; Agarwal AM
J Perinatol; 2014 Aug; 34(8):616-9. PubMed ID: 24762414
[TBL] [Abstract][Full Text] [Related]
10. The value of transcutaneous method of bilirubin measurement in newborn population with the risk of ABO hemolytic disease.
Stoniene D; Buinauskiene J; Markūniene E
Medicina (Kaunas); 2009; 45(10):792-7. PubMed ID: 19996666
[TBL] [Abstract][Full Text] [Related]
11. [Remote monitoring of neonatal jaundice in newborns with ABO hemolytic disease].
Xu C; Bao Y; Zhu J; Teng Y; He Y; Cheng K; Ji F; Wu M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 49(5):651-655. PubMed ID: 33210495
[TBL] [Abstract][Full Text] [Related]
12. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
Ercin S; Coskun Y; Kayas K; Kavas N; Gursoy T
Am J Perinatol; 2024 Mar; 41(4):505-510. PubMed ID: 34847590
[TBL] [Abstract][Full Text] [Related]
13. ABO hemolytic disease of newborn : Does newborn's blood group a risk factor?
Bel Hadj I; Boukhris R; Khalsi F; Namouchi M; Bougmiza I; Tinsa F; Hamouda S; Boussetta K
Tunis Med; 2019 Mar; 97(3):455-460. PubMed ID: 31729720
[TBL] [Abstract][Full Text] [Related]
14. Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system.
Christensen RD; Lambert DK; Henry E; Eggert LD; Yaish HM; Reading NS; Prchal JT
Blood Cells Mol Dis; 2013 Feb; 50(2):105-9. PubMed ID: 23123126
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
Chen JY; Ling UP
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
[TBL] [Abstract][Full Text] [Related]
16. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
Johnson L; Bhutani VK; Karp K; Sivieri EM; Shapiro SM
J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn.
Calkins K; Roy D; Molchan L; Bradley L; Grogan T; Elashoff D; Walker V
J Neonatal Perinatal Med; 2015; 8(3):243-50. PubMed ID: 26518407
[TBL] [Abstract][Full Text] [Related]
18. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
[TBL] [Abstract][Full Text] [Related]
19. Decreased neonatal jaundice readmission rate after implementing hyperbilirubinemia guidelines and universal screening for bilirubin.
Alkalay AL; Bresee CJ; Simmons CF
Clin Pediatr (Phila); 2010 Sep; 49(9):830-3. PubMed ID: 20693521
[TBL] [Abstract][Full Text] [Related]
20. ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases.
Dufour DR; Monoghan WP
Am J Clin Pathol; 1980 Mar; 73(3):369-73. PubMed ID: 7189092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
